Related Experiment Video

Updated: Jun 12, 2026

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level
05:35

A Point-of-Care Method with Integrated Decision Support Tool to Estimate Anemia at Population Level

Published on: January 19, 2024

Evaluation of anemia in children

Jennifer Janus1, Sarah K Moerschel

  • 1Johns Hopkins Community Physicians, Hagerstown, MD, USA. jcox21@jhmi.edu

American Family Physician
|June 15, 2010
PubMed

Insights

Anemia, a low hemoglobin level, is often asymptomatic in children and detected via screening. Classification depends on red blood cell size, guiding diagnosis and treatment for various anemia types.

Area of Science:

  • Pediatrics
  • Hematology

Background:

  • Anemia is defined as hemoglobin below the 5th percentile for age, with varied causes.
  • Most pediatric anemia cases are asymptomatic and found during screening, recommended for high-risk children.

Purpose of the Study:

  • To outline the classification, evaluation, and management of anemia in children.
  • To differentiate diagnostic approaches based on anemia morphology (microcytic, normocytic, macrocytic).

Main Methods:

  • Classification based on mean corpuscular volume (MCV): microcytic, normocytic, macrocytic.
  • Diagnostic workup includes screening, iron studies, lead levels, hemoglobin electrophoresis, reticulocyte count, vitamin B12, folate, and thyroid function tests.
  • Peripheral smear analysis aids in evaluating anemia of any morphology.

Main Results:

  • Mild microcytic anemia in 6-36 month olds with risk factors may be treated with oral iron.
  • Severe or unresponsive anemia warrants investigation for gastrointestinal blood loss.
  • Normocytic anemia evaluation depends on reticulocyte count, distinguishing hemolysis/blood loss from bone marrow disorders.
  • Macrocytic anemia workup involves vitamin B12, folate, and thyroid function tests.

Conclusions:

  • Anemia diagnosis and management in children are guided by MCV classification and specific laboratory evaluations.
  • Prompt identification and appropriate workup are crucial for effective anemia treatment in pediatric populations.

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
Factors Affecting Erythropoiesis01:24

Factors Affecting Erythropoiesis

The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...